FACT CHECK: Did Mark Cuban Move His Drug Company From Texas To California?

Anthony Pascone | Contributor

A post on Threads claims that billionaire and Dallas Mavericks owner Mark Cuban moved his “Cost Plus Drugs” company to California.

 

View on Threads

 

Verdict: False

Cuban has not announced that the move has happened nor has he mentioned any plans to do this.

Fact Check:

Cuban is currently the c0-founder of “Mark Cuban Cost Plus Drug Company,” which purports to provide pharmaceutical medications at a cheaper price without insurance. Headquartered in Dallas, the company’s stated goal is to reduce the cost of drugs and bring transparency to the process.

A post on Threads claims that Cuban will be moving Cost Plus’ headquarters out of Texas and relocating to California. The reasoning, cut off mid-sentence in the caption, claims Cuban was quoted as saying “can’t operate in Red states due to those who tried to block….” along with a link.

This information and quote is incorrect. There is no proof that Cuban said any of this or that there are plans in motion to move Cost Plus Drugs anywhere.

The Threads post links to an article on “Best Celebrity Zone,” which also features explicit images of women intertwined with the allege article. It says Cuban’s full quote was “I can’t operate in red-states anymore. The political climate and policies being enforced in these states make it increasingly difficult to run a business that values inclusivity and fairness.” A Google search for more reputable sources with this quote turned up empty.

In fact, Cuban’s company is planning to begin manufacturing of its own drugs in Texas some time in January 2025, according to Yahoo. The statement was made at a White House roundtable around lowering health care costs, the outlet reported. (RELATED: No, Mark Cuban’s Net Worth Did Not Take A $1 Billion Hit After Endorsing Kamala Harris)

The terms page on the Cost Plus Drugs company website still lists their facilities to be in Dallas. This story was first reported by Lead Stories.

Anthony Pascone

Contributor

Trending